How much does it cost for pregnant women to do non-invasive DNA

For some pregnant women, when they go to the hospital for prenatal check-ups, the doctor requires a minimally invasive DNA test; for some pregnant women, the doctor does not require it. Generally speaking, doctors will order minimally invasive DNA testing for older pregnant women, but those who have previously undergone Down syndrome screening do not need to do it again. Minimally invasive surgery is also a way to detect fetal malformations. How much does it cost to do non-invasive surgery during pregnancy?

How much does it cost to have non-invasive pregnancy

The price of minimally invasive DNA testing varies in every hospital and every city. It’s about 1,500 to 2,000 yuan, and it may be more expensive in more developed cities. Go to a local hospital to inquire about the price.

Minimally invasive DNA prenatal testing is also known as minimally invasive prenatal DNA testing, minimally invasive fetal sex chromosome aneuploidy testing, etc. According to the American Association of Colleges of Obstetricians and Gynaecologists, an international authoritative academic research organization, minimally invasive prenatal DNA testing (Non-invasive Prenatal Testing) is the name of the most widely used technology. The minimally invasive DNA prenatal non-destructive testing technology only uses the pregnant woman's venous blood, and uses the next-generation DNA sequencing technology to sequence the mineralogic DNA fragments (including the fetal mineralogic DNA) in the pregnant woman's jugular venous blood. The sequencing results are then analyzed for biometric characteristics, from which the fetus's genetic material can be obtained, thereby testing whether the fetus suffers from the three major sex chromosome diseases.

Minimally invasive DNA prenatal non-destructive testing technology is a safe, accurate and rapid new non-destructive testing technology for fetal sex chromosome disorders. This technology only needs to extract venous blood from pregnant women to accurately determine whether the fetus suffers from sex chromosome diseases such as Down syndrome, Maria syndrome, Patau syndrome, etc.

The blood of pregnant women contains fetal mineral DNA, which provides a practical basis for this project. Fetal chromosomal abnormalities will cause a small change in the DNA composition of the pregnant mother. This change can be analyzed and detected through deep sequencing and biological characteristics, providing theoretical significance for the new project.